There is still no green light for the stock market as the 2024 presidential election season gets into full swing. The S&P 500’s historical performance during election years suggests stocks could experience a lackluster and volatile period between now and Nov. 5.
The U.S. created a remarkable 242,000 jobs a month from the spring of 2023 to the spring of 2024, when the economy was thought be slowing down. Or did it?
The deal will make Trimont the largest servicer of commercial loans in the United States, the company said.
Kroger Co. is expected to price what may be the biggest bond deal of 2024 later Tuesday, a seven-part deal that will be used to help fund its $25 billion planed merger with Albertsons Cos.
You may be investing for retirement all wrong, one financial planner says.
There’s a new twist in the ongoing debate over whether drugs widely used for weight loss are linked with thoughts of self-injury or suicide.
Defensive stocks like consumer staples and utilities have recently come back in vogue, and that is making some investors nervous.
Media executive Edgar Bronfman Jr. has submitted a $4.3 billion offer for National Amusements in an attempt to upend a previous agreement to merge it with David Ellison’s Skydance Media, according to the Wall Street Journal.
Lewis Altfest provided three examples of municipal bonds whose yields are way above those of U.S. Treasury notes of similar maturities on a taxable-equivalent basis.
Orders for recreational vehicles drop, but D.A. Davidson analyst sees REV Group and Shyft Group as buys.
FuelCell Energy said Tuesday it will hold a special meeting of shareholders to ask them to vote on a proposal that will allow the fuel-cell technology company to enact a reverse stock split.
GeoVax shares have been on a tear since the World Health Organization declared mpox a public-health emergency of international concern.
The European Commission said it plans to place a 9% tariff on Tesla imports — down from a previously proposed tariff of above 20%.
The Federal Reserve will use its Jackson Hole retreat to outline to markets a gradual easing plan beginning at its mid-September meeting, economists said, ahead of the two days of discussions that will start Friday.
Eli Lilly’s stock gained more than 2% premarket on Tuesday after the drugmaker said that tirzepatide, marketed as the diabetes drug Mounjaro and weight-loss treatment Zepbound, sharply cut patients’ risk of developing Type 2 diabetes in a late-stage trial.
While one analyst said latest deal could help AMD “potentially close the gap” with Nvidia over several years, another said the move still “doesn’t level the playing field.”
The device, which can be inserted through a minimally invasive catheter-based procedure, received FDA Breakthrough Device Designation in 2019 and has the potential to become the first device of its kind to market, Johnson & Johnson said.
Harris has not proposed sweeping price controls — on food, rents or anything else.
Analysts are curious about potential shipment delays for the new Blackwell chip but see plenty of reason to cheer Nvidia’s long-term opportunity.
Palo Alto Networks said it’s seeing progress as it seeks to drive customer adoption of a broader suite of services, but some investors may quibble with deceleration on a key metric.
